Tristetraprolin Inhibits the Growth of Human Glioma Cells through Downregulation of Urokinase Plasminogen Activator/Urokinase Plasminogen Activator Receptor mRNAs
- Authors
- Ryu, Jinhyun; Yoon, Nal Ae; Lee, Yeon Kyung; Jeong, Joo Yeon; Kang, Seokmin; Seong, Hyemin; Choi, Jungil; Park, Nammi; Kim, Nayoung; Cho, Wha Ja; Paek, Sun Ha; Cho, Gyeong Jae; Choi, Wan Sung; Park, Jae-Yong; Park, Jeong Woo; Kang, Sang Soo
- Issue Date
- 2월-2015
- Publisher
- KOREAN SOC MOLECULAR & CELLULAR BIOLOGY
- Keywords
- glioma; TTP; uPA; uPAR
- Citation
- MOLECULES AND CELLS, v.38, no.2, pp.156 - 162
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- MOLECULES AND CELLS
- Volume
- 38
- Number
- 2
- Start Page
- 156
- End Page
- 162
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/94589
- DOI
- 10.14348/molcells.2015.2259
- ISSN
- 1016-8478
- Abstract
- Urokinase plasminogen activator (uPA) and urokinase plasminogen activator receptor (uPAR) play a major role in the infiltrative growth of glioblastoma. Downregulatoion of the uPA and uPAR has been reported to inhibit the growth glioblastoma. Here, we demonstrate that tristetraprolin (TTP) inhibits the growth of U87MG human glioma cells through downregulation of uPA and uPAR. Our results show that expression level of TTP is inversely correlated with those of uPA and uPAR in human glioma cells and tissues. TTP binds to the AU-rich elements within the 3' untranslated regions of uPA and uPAR and overexpression of TTP decreased the expression of uPA and uPAR through enhancing the degradation of their mRNAs. In addition, overexpression of TTP inhibited the growth and invasion of U87MG cells. Our findings implicate that TTP can be used as a promising therapeutic target to treat human glioma.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Health Sciences > School of Biosystems and Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.